Jennifer Doan

Array ( [id] => 7169517 [patent_doc_number] => 20040077658 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists' [patent_app_type] => new [patent_app_number] => 10/416600 [patent_app_country] => US [patent_app_date] => 2003-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11059 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20040077658.pdf [firstpage_image] =>[orig_patent_app_number] => 10416600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7325439 [patent_doc_number] => 20040138232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Acyl derivatives of 5-(2-(4-(1,2 benzisothiazole-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one having neuroleptic activity' [patent_app_type] => new [patent_app_number] => 10/689773 [patent_app_country] => US [patent_app_date] => 2003-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5751 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138232.pdf [firstpage_image] =>[orig_patent_app_number] => 10689773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 404712 [patent_doc_number] => 07288545 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-30 [patent_title] => 'Piperazinedione compounds' [patent_app_type] => utility [patent_app_number] => 10/689865 [patent_app_country] => US [patent_app_date] => 2003-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6194 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/288/07288545.pdf [firstpage_image] =>[orig_patent_app_number] => 10689865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 418828 [patent_doc_number] => 07276500 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-02 [patent_title] => 'Substituted amides, their preparation and use' [patent_app_type] => utility [patent_app_number] => 10/690400 [patent_app_country] => US [patent_app_date] => 2003-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12876 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/276/07276500.pdf [firstpage_image] =>[orig_patent_app_number] => 10690400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7089960 [patent_doc_number] => 20050010031 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Melanocortin receptor ligands' [patent_app_type] => utility [patent_app_number] => 10/689022 [patent_app_country] => US [patent_app_date] => 2003-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 87996 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20050010031.pdf [firstpage_image] =>[orig_patent_app_number] => 10689022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7207447 [patent_doc_number] => 20040087593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => '4-Piperazinyl benzenesulfonyl indoles and uses thereof' [patent_app_type] => new [patent_app_number] => 10/687091 [patent_app_country] => US [patent_app_date] => 2003-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10121 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20040087593.pdf [firstpage_image] =>[orig_patent_app_number] => 10687091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 475397 [patent_doc_number] => 07226922 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-05 [patent_title] => 'Imidazo[1,2-b]pyridazine analogues as anxiolytics and cognition enhancers' [patent_app_type] => utility [patent_app_number] => 10/680855 [patent_app_country] => US [patent_app_date] => 2003-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8690 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/226/07226922.pdf [firstpage_image] =>[orig_patent_app_number] => 10680855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7225327 [patent_doc_number] => 20040072845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Enantiomers of 1-[ (4-chlorophenyl) phenylmethyl ] -4-[ (4-methylphenyl) sulfonyl] piperazine' [patent_app_type] => new [patent_app_number] => 10/679376 [patent_app_country] => US [patent_app_date] => 2003-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11065 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072845.pdf [firstpage_image] =>[orig_patent_app_number] => 10679376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7453684 [patent_doc_number] => 20040067959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-08 [patent_title] => 'Morphinoid derivatives as delta-opioid agonists and antagonists' [patent_app_type] => new [patent_app_number] => 10/398313 [patent_app_country] => US [patent_app_date] => 2003-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6277 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0067/20040067959.pdf [firstpage_image] =>[orig_patent_app_number] => 10398313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7672899 [patent_doc_number] => 20040180880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Piperazine and piperidine derivatives' [patent_app_type] => new [patent_app_number] => 10/677631 [patent_app_country] => US [patent_app_date] => 2003-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8409 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180880.pdf [firstpage_image] =>[orig_patent_app_number] => 10677631 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7306186 [patent_doc_number] => 20040116433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Inhibitors of akt activity' [patent_app_type] => new [patent_app_number] => 10/473786 [patent_app_country] => US [patent_app_date] => 2003-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9996 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20040116433.pdf [firstpage_image] =>[orig_patent_app_number] => 10473786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 468960 [patent_doc_number] => 07232826 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-19 [patent_title] => 'Tyrosine kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/674098 [patent_app_country] => US [patent_app_date] => 2003-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17331 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/232/07232826.pdf [firstpage_image] =>[orig_patent_app_number] => 10674098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7325417 [patent_doc_number] => 20040138224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Pyrrolidine sulfonamides' [patent_app_type] => new [patent_app_number] => 10/472976 [patent_app_country] => US [patent_app_date] => 2003-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5067 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138224.pdf [firstpage_image] =>[orig_patent_app_number] => 10472976 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7474694 [patent_doc_number] => 20040097515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Antimicrobial drug reduced in effect on heart' [patent_app_type] => new [patent_app_number] => 10/472183 [patent_app_country] => US [patent_app_date] => 2003-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3673 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20040097515.pdf [firstpage_image] =>[orig_patent_app_number] => 10472183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7453690 [patent_doc_number] => 20040067960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-08 [patent_title] => 'Heterocyclic substituted piperazines for the treatment of schizophrenia' [patent_app_type] => new [patent_app_number] => 10/672949 [patent_app_country] => US [patent_app_date] => 2003-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21835 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0067/20040067960.pdf [firstpage_image] =>[orig_patent_app_number] => 10672949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7392409 [patent_doc_number] => 20040083447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => '1-Phenyl-4-benzylpiperazines dopamine receptor subtype specific ligands' [patent_app_type] => new [patent_app_number] => 10/667821 [patent_app_country] => US [patent_app_date] => 2003-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3766 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20040083447.pdf [firstpage_image] =>[orig_patent_app_number] => 10667821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7325435 [patent_doc_number] => 20040138230 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Heterocyclic substituted piperazines for the treatment of schizophrenia' [patent_app_type] => new [patent_app_number] => 10/660908 [patent_app_country] => US [patent_app_date] => 2003-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44244 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138230.pdf [firstpage_image] =>[orig_patent_app_number] => 10660908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7270414 [patent_doc_number] => 20040058932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-25 [patent_title] => 'Novel piperazine derivatives' [patent_app_type] => new [patent_app_number] => 10/660052 [patent_app_country] => US [patent_app_date] => 2003-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22209 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20040058932.pdf [firstpage_image] =>[orig_patent_app_number] => 10660052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7674614 [patent_doc_number] => 20040127504 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Benzimidazoles that are useful in treating sexual dysfunction' [patent_app_type] => new [patent_app_number] => 10/656672 [patent_app_country] => US [patent_app_date] => 2003-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 28007 [patent_no_of_claims] => 113 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127504.pdf [firstpage_image] =>[orig_patent_app_number] => 10656672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7105317 [patent_doc_number] => 20050107395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Pyridinyl-methyl-ethyl cyclohexanecarboxamides as serotonergic agents' [patent_app_type] => utility [patent_app_number] => 10/652420 [patent_app_country] => US [patent_app_date] => 2003-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7297 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20050107395.pdf [firstpage_image] =>[orig_patent_app_number] => 10652420 [rel_patent_id] =>[rel_patent_doc_number] =>)